Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128690) titled 'Observation of Iris Blood Flow via OCTA in Diabetic Neovascular Glaucoma' on July 24.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Qilu Hospital of Shandong University
Condition:
Type 2 diabetic neovascular glaucoma
Intervention:
Group with type 2 diabetes without retinopathy:None
Normal control group:None
Group with type 2 diabetic retinopathy:None
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-07-27
Target Sample Size: Group with type 2 diabetes without retinopathy:28;Normal control group:28;Group with type 2 diabetic retinopathy:28;Typ...